Business Description

Fresenius SE & Co KGaA
ISIN : DE0005785604
Share Class Description:
XTER:FRE: Ordinary SharesCompare
Compare
Traded in other countries / regions
FRE.Germany0OO9.UKFSNUY.USAFREN.MexicoFRE.ItalyFRE.AustriaFRE.Switzerland IPO Date
1992-08-06Description
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.07 | |||||
Equity-to-Asset | 0.27 | |||||
Debt-to-Equity | 0.76 | |||||
Debt-to-EBITDA | 2.08 | |||||
Interest Coverage | 4.4 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.29 | |||||
Beneish M-Score | -3.26 | |||||
WACC vs ROIC |
Growth Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 4.7 | |||||
3-Year EBITDA Growth Rate | -3.8 | |||||
3-Year EPS without NRI Growth Rate | -2.6 | |||||
3-Year Book Growth Rate | 6.5 | |||||
Future 3-5Y EPS without NRI Growth Rate | 9.4 | |||||
Future 3-5Y Total Revenue Growth Rate | -7.53 |
Momentum Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 91.87 | |||||
9-Day RSI | 80.13 | |||||
14-Day RSI | 70.19 | |||||
6-1 Month Momentum % | -9.07 | |||||
12-1 Month Momentum % | -6.93 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.54 | |||||
Quick Ratio | 1.44 | |||||
Cash Ratio | 0.04 | |||||
Days Inventory | 42.91 | |||||
Days Sales Outstanding | 49.36 | |||||
Days Payable | 18.09 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 3.22 | |||||
Dividend Payout Ratio | 0.55 | |||||
3-Year Dividend Growth Rate | 4.8 | |||||
Forward Dividend Yield % | 3.22 | |||||
5-Year Yield-on-Cost % | 4.6 | |||||
3-Year Average Share Buyback Ratio | -0.3 | |||||
Shareholder Yield % | 21.97 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 25.19 | |||||
Operating Margin % | 6.9 | |||||
Net Margin % | 0.54 | |||||
FCF Margin % | 4.36 | |||||
ROE % | 1.34 | |||||
ROA % | 0.36 | |||||
ROIC % | 3.38 | |||||
ROC (Joel Greenblatt) % | 14.97 | |||||
ROCE % | 6.28 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 55.76 | |||||
Forward PE Ratio | 9.78 | |||||
PE Ratio without NRI | 9.9 | |||||
Shiller PE Ratio | 8.58 | |||||
Price-to-Owner-Earnings | 78.96 | |||||
PEG Ratio | 33 | |||||
PS Ratio | 0.3 | |||||
PB Ratio | 0.77 | |||||
Price-to-Tangible-Book | 9.78 | |||||
Price-to-Free-Cash-Flow | 6.78 | |||||
Price-to-Operating-Cash-Flow | 3.3 | |||||
EV-to-EBIT | 8.12 | |||||
EV-to-Forward-EBIT | 11.63 | |||||
EV-to-EBITDA | 4.16 | |||||
EV-to-Forward-EBITDA | 7.04 | |||||
EV-to-Revenue | 0.58 | |||||
EV-to-Forward-Revenue | 1.24 | |||||
EV-to-FCF | 13.2 | |||||
Price-to-Projected-FCF | 0.54 | |||||
Price-to-Median-PS-Value | 0.35 | |||||
Price-to-Graham-Number | 2.12 | |||||
Earnings Yield (Greenblatt) % | 12.3 | |||||
FCF Yield % | 13.85 | |||||
Forward Rate of Return (Yacktman) % | 10.27 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Fresenius SE & Co KGaA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 51,080 | ||
EPS (TTM) (€) | 0.49 | ||
Beta | 0.97 | ||
Volatility % | 28.18 | ||
14-Day RSI | 70.19 | ||
14-Day ATR (€) | 0.591075 | ||
20-Day SMA (€) | 26.694 | ||
12-1 Month Momentum % | -6.93 | ||
52-Week Range (€) | 23.29 - 31.22 | ||
Shares Outstanding (Mil) | 563.24 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 6 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Fresenius SE & Co KGaA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Fresenius SE & Co KGaA Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Fresenius SE & Co KGaA Frequently Asked Questions
What is Fresenius SE & Co KGaA(XTER:FRE)'s stock price today?
The current price of XTER:FRE is €28.57. The 52 week high of XTER:FRE is €31.22 and 52 week low is €23.29.
When is next earnings date of Fresenius SE & Co KGaA(XTER:FRE)?
The next earnings date of Fresenius SE & Co KGaA(XTER:FRE) is 2024-02-21 Est..
Does Fresenius SE & Co KGaA(XTER:FRE) pay dividends? If so, how much?
The Dividend Yield %  of Fresenius SE & Co KGaA(XTER:FRE) is 3.22% (As of Today), Highest Dividend Payout Ratio of Fresenius SE & Co KGaA(XTER:FRE) was 0.55. The lowest was 0.19. And the median was 0.24. The  Forward Dividend Yield % of Fresenius SE & Co KGaA(XTER:FRE) is 3.22%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |